Literature DB >> 6864206

Relationships between brain concentrations of desipramine and paradoxical sleep inhibition in the rat.

P Baumann, J M Gaillard, M Perey, J C Justafré, P Le.   

Abstract

Desipramine (DMI), like many antidepressant drugs, inhibit the production of paradoxical sleep (PS). In the present experiment, we have investigated the relationships between brain level of DMI and PS inhibition. Groups of rats had their sleep monitored after 1, 2 or 4 mg/kg of DMI. In other animals, the brain concentration of DMI was assayed at various times after the same treatments. The results indicate that a critical threshold concentration of 300 ng/g DMI in the brain is necessary for complete PS inhibition. This stage reappears only when the DMI level falls below this value, and its production resumes at a normal rate, provided the DMI level reached initially was not largely in excess of the threshold concentration. The results are discussed with regard to the present knowledge of specific binding of tricyclics in brain and their "ex vivo" action on norepinephrine uptake resulting in enhancement of collateral inhibiton of noradrenergic cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864206     DOI: 10.1007/bf01243270

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  22 in total

1.  Temporal organization of human sleep: general trends of sleep stages and their ultradian cyclic components.

Authors:  J M Gaillard
Journal:  Encephale       Date:  1979       Impact factor: 1.291

2.  Gas chromatographic determination of dibenzepine and its basic metabolites in biological material.

Authors:  H J Schlicht; H P Gelbke
Journal:  J Chromatogr       Date:  1978-12-11

3.  The effects of long term administration of psychotropic drugs on human sleep. 3. The effects of amitriptyline.

Authors:  E Hartmann; J Cravens
Journal:  Psychopharmacologia       Date:  1973

4.  [Sleep privation with eye movements using antidepressive agents].

Authors:  P Passouant; J Cadilhac; M Ribstein
Journal:  Rev Neurol (Paris)       Date:  1972-07       Impact factor: 2.607

Review 5.  The pharmacology of rapid eye movement sleep.

Authors:  C D King
Journal:  Adv Pharmacol Chemother       Date:  1971

6.  Pharmacokinetic linearity of desipramine hydrochloride.

Authors:  D Weiner; D Garteiz; M Cawein; T Dusebout; G Wright; R Okerholm
Journal:  J Pharm Sci       Date:  1981-09       Impact factor: 3.534

7.  3H-imipramine binding in neuronal and glial fractions of horse striatum.

Authors:  M S Briley; G Fillion; D Beaudoin; M P Fillion; S Z Langer
Journal:  Eur J Pharmacol       Date:  1980-06-13       Impact factor: 4.432

8.  Specific tricyclic antidepressant binding sites in rat brain.

Authors:  R Raisman; M Briley; S Z Langer
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

9.  The in vivo distribution of an antidepressant drug (DMI) in male and female rats.

Authors:  A Biegon; D Samuel
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

10.  On the role of brain alpha-adrenergic systems in the production of paradoxical sleep.

Authors:  J M Gaillard; S Kafi; J C Justafre
Journal:  Encephale       Date:  1982       Impact factor: 1.291

View more
  7 in total

1.  Absence of stereoselectivity of some tricyclic antidepressants for the inhibition of depolarization-induced calcium uptake in rat cingulate cortex synaptosomes.

Authors:  P A Lavoie; G Beauchamp; R Elie
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

2.  Effects of monoamine uptake inhibitors given early postnatally on monoamines in the brain stem, caudate/putamen and cortex, and on dopamine D1 and D2 receptors in the caudate/putamen.

Authors:  I Hilakivi; L Ahtee; J O Rinne; T Taira; L M Attila; P Marjamaki
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants.

Authors:  Caroline Nothdurfter; Sascha Tanasic; Barbara Di Benedetto; Gerhard Rammes; Eva-Maria Wagner; Thomas Kirmeier; Vanessa Ganal; Julia S Kessler; Theo Rein; Florian Holsboer; Rainer Rupprecht
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

4.  Antidepressant suppression of non-REM sleep spindles and REM sleep impairs hippocampus-dependent learning while augmenting striatum-dependent learning.

Authors:  Alain Watts; Howard J Gritton; Jamie Sweigart; Gina R Poe
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

5.  Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies.

Authors:  P Baumann; J M Gaillard; M Jonzier-Perey; C Gerber; C Bouras
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients.

Authors:  J E Shipley; D J Kupfer; S J Griffin; R S Dealy; P A Coble; A B McEachran; V J Grochocinski; R Ulrich; J M Perel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Neonatal desipramine or zimeldine treatment causes long-lasting changes in brain monoaminergic systems and alcohol related behavior in rats.

Authors:  L A Hilakivi; D Stenberg; J D Sinclair; K Kiianmaa
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.